Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 27

References for PMC Articles for PubMed (Select 17897635)


A carboxyl-terminal hydrophobic interface is critical to sodium channel function. Relevance to inherited disorders.

Glaaser IW, Bankston JR, Liu H, Tateyama M, Kass RS.

J Biol Chem. 2006 Aug 18;281(33):24015-23. Epub 2006 Jun 22.


Sodium channel inactivation in heart: a novel role of the carboxy-terminal domain.

Kass RS.

J Cardiovasc Electrophysiol. 2006 May;17 Suppl 1:S21-S25. Review.


Partial expression defect for the SCN5A missense mutation G1406R depends on splice variant background Q1077 and rescue by mexiletine.

Tan BH, Valdivia CR, Song C, Makielski JC.

Am J Physiol Heart Circ Physiol. 2006 Oct;291(4):H1822-8. Epub 2006 Apr 21.


New mechanism contributing to drug-induced arrhythmia: rescue of a misprocessed LQT3 mutant.

Liu K, Yang T, Viswanathan PC, Roden DM.

Circulation. 2005 Nov 22;112(21):3239-46.


Impaired impulse propagation in Scn5a-knockout mice: combined contribution of excitability, connexin expression, and tissue architecture in relation to aging.

van Veen TA, Stein M, Royer A, Le Quang K, Charpentier F, Colledge WH, Huang CL, Wilders R, Grace AA, Escande D, de Bakker JM, van Rijen HV.

Circulation. 2005 Sep 27;112(13):1927-35. Epub 2005 Sep 19.


Common human SCN5A polymorphisms have altered electrophysiology when expressed in Q1077 splice variants.

Tan BH, Valdivia CR, Rok BA, Ye B, Ruwaldt KM, Tester DJ, Ackerman MJ, Makielski JC.

Heart Rhythm. 2005 Jul;2(7):741-7.


A mutation in the human cardiac sodium channel (E161K) contributes to sick sinus syndrome, conduction disease and Brugada syndrome in two families.

Smits JP, Koopmann TT, Wilders R, Veldkamp MW, Opthof T, Bhuiyan ZA, Mannens MM, Balser JR, Tan HL, Bezzina CR, Wilde AA.

J Mol Cell Cardiol. 2005 Jun;38(6):969-81. Epub 2005 Apr 1.


A trafficking defective, Brugada syndrome-causing SCN5A mutation rescued by drugs.

Valdivia CR, Tester DJ, Rok BA, Porter CB, Munger TM, Jahangir A, Makielski JC, Ackerman MJ.

Cardiovasc Res. 2004 Apr 1;62(1):53-62.


The Na+ channel inactivation gate is a molecular complex: a novel role of the COOH-terminal domain.

Motoike HK, Liu H, Glaaser IW, Yang AS, Tateyama M, Kass RS.

J Gen Physiol. 2004 Feb;123(2):155-65.


Congenital sick sinus syndrome caused by recessive mutations in the cardiac sodium channel gene (SCN5A).

Benson DW, Wang DW, Dyment M, Knilans TK, Fish FA, Strieper MJ, Rhodes TH, George AL Jr.

J Clin Invest. 2003 Oct;112(7):1019-28.


A ubiquitous splice variant and a common polymorphism affect heterologous expression of recombinant human SCN5A heart sodium channels.

Makielski JC, Ye B, Valdivia CR, Pagel MD, Pu J, Tester DJ, Ackerman MJ.

Circ Res. 2003 Oct 31;93(9):821-8. Epub 2003 Sep 18.


Prevalence and severity of "benign" mutations in the beta-myosin heavy chain, cardiac troponin T, and alpha-tropomyosin genes in hypertrophic cardiomyopathy.

Van Driest SL, Ackerman MJ, Ommen SR, Shakur R, Will ML, Nishimura RA, Tajik AJ, Gersh BJ.

Circulation. 2002 Dec 10;106(24):3085-90.


A common human SCN5A polymorphism modifies expression of an arrhythmia causing mutation.

Ye B, Valdivia CR, Ackerman MJ, Makielski JC.

Physiol Genomics. 2003 Feb 6;12(3):187-93.


Long QT syndrome, Brugada syndrome, and conduction system disease are linked to a single sodium channel mutation.

Grant AO, Carboni MP, Neplioueva V, Starmer CF, Memmi M, Napolitano C, Priori S.

J Clin Invest. 2002 Oct;110(8):1201-9.


Defective cardiac ion channels: from mutations to clinical syndromes.

Clancy CE, Kass RS.

J Clin Invest. 2002 Oct;110(8):1075-7. Review. No abstract available.


A novel SCN5A arrhythmia mutation, M1766L, with expression defect rescued by mexiletine.

Valdivia CR, Ackerman MJ, Tester DJ, Wada T, McCormack J, Ye B, Makielski JC.

Cardiovasc Res. 2002 Aug 1;55(2):279-89.


Evolution of voltage-gated Na(+) channels.

Goldin AL.

J Exp Biol. 2002 Mar;205(Pt 5):575-84. Review.


A mutant cardiac sodium channel with multiple biophysical defects associated with overlapping clinical features of Brugada syndrome and cardiac conduction disease.

Shirai N, Makita N, Sasaki K, Yokoi H, Sakuma I, Sakurada H, Akai J, Kimura A, Hiraoka M, Kitabatake A.

Cardiovasc Res. 2002 Feb 1;53(2):348-54.


Novel SCN5A mutation leading either to isolated cardiac conduction defect or Brugada syndrome in a large French family.

Kyndt F, Probst V, Potet F, Demolombe S, Chevallier JC, Baro I, Moisan JP, Boisseau P, Schott JJ, Escande D, Le Marec H.

Circulation. 2001 Dec 18;104(25):3081-6.


Secondary structure of the human cardiac Na+ channel C terminus: evidence for a role of helical structures in modulation of channel inactivation.

Cormier JW, Rivolta I, Tateyama M, Yang AS, Kass RS.

J Biol Chem. 2002 Mar 15;277(11):9233-41. Epub 2001 Dec 10.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk